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Purpose: Vitreoretinal disorders lack specific biomarkers that define either disease type or response to treatment. We
have used NMR-based metabolomic analysis of human vitreous humor to assess the applicability of this approach to the
study of ocular disease.
Methods: Vitreous samples from patients with a range of vitreoretinal disorders were subjected to high-resolution 1H-
nuclear magnetic resonance spectroscopy (NMR). Good quality spectra were derived from the vitreous samples, and the
profiles were analyzed by three different methods.
Results: Principal component analysis (PCA) showed a wide dispersal of the different clinical conditions. Partial least
squares discriminant analysis (PLS-DA) was used to define differences between lens-induced uveitis (LIU) and chronic
uveitis (CU) and could distinguish between these conditions with a sensitivity of 78% and specificity of 85%. A genetic
algorithm coupled with multivariate classification identified a small number of spectral components that showed clear
discrimination between LIU and CU samples with sensitivity and specificity >90%. Assignment of specific resonances
indicated that some metabolites involved in the arginase pathway were significantly more abundant in LIU than CU.
Conclusion: The discrimination we observed based on PCA, PLS-DA, and multivariate variable selection analysis of the
NMR spectra suggests that a complex mix of metabolites are present in vitreous fluid of different uveitic conditions as a
result of the disease process. Collectively the data demonstrates the efficacy of metabolomic analysis to distinguish
between ocular inflammatory diseases.
Vitreoretinal disorders encompass a complex group of
diseases with different pathogenetic mechanisms including
inflammatory and proliferative conditions. Many of these,
such as uveitis, lack specific biomarkers that define either
disease type or response to treatment. A range of possible
endpoints is used to define outcome, but it is not clear how
these relate to each other in different patients or studies [1].
This is particularly relevant for clinical trials when comparing
a novel treatment to established therapy. Several studies have
identified  inflammatory  mediators,  such  as  cytokines,
chemokines,  and  growth  factors  or  single  nucleotide
polymorphisms with disease type, activity, and response to
treatment, yet there is no clear result that can relate to clinical
response [2-6]. This, in part, results from the narrowly focused
analysis of particular candidate molecules or single nucleotide
polymorphisms  (SNP),  selection  of  which  is  based  on
knowledge of disease type and the immune response. More
recently,  multiplex  protein  and  gene  analysis  have  been
utilized in ocular disease and results have shown profiles of
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interest, although in the case of proteins, still within a selected
group of molecules [7-9].
An  even  broader  global  profiling  of  the  network  of
proteins or metabolites found in cells, tissues or fluids can
increase  our  understanding  of  the  multiple  interacting
processes involved in complex systems. One such approach
is metabolomics, which analyses the metabolic consequences
of gene expression and protein activity [10]. Metabolomics
most  often  combines  either  high-field  nuclear  magnetic
resonance  or  mass  spectrometry  of  biofluids  with  pattern
recognition  (principal  components  analysis)  within  the
resulting dataset. It is based on the concept that metabolic
properties of tissues predispose to or are altered by disease
processes, and these changes can be reflected in characteristic
patterns (metabolomic profile) in blood, urine, or other body
fluids.
Metabolomics has been applied to the study of coronary
heart  disease,  where  analysis  of  serum  nuclear  magnetic
resonance (NMR) spectra appeared to distinguish between
different degrees of coronary artery stenosis. The features in
the NMR spectra contributing to this discrimination were
largely  lipid  components  and  yet  classical  biochemical
analysis of the usual lipid profiles was unable to discriminate
between these patients [11]. Recently, metabolomic analysis
has  been  reported  to  discriminate  in   the  prognosis   and
diagnosis of other human diseases, including diabetes, blood
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1210pressure, and cancer [12-14]. In a study of prostate cancer a
novel metabolic marker of potential prognostic importance
was recently identified which was derived from a pathway not
previously associated with this disease [15]. Thus it seems that
the  multiplexed  analysis  inherent  in  this  approach,  which
takes into account all metabolite signals regardless of whether
they  have  been  specifically  identified,  is  able  to  provide
information not available by other means.
The analysis of eye disease using such approaches has
been reported, but this has been limited to investigations of
animal models. For example, significant changes in a number
of metabolites in rabbit eye aqueous humor [16] and in rat lens
[17] has been seen following UV-B exposure, and a rise in
lactate in vitreous humor has been observed in a rabbit model
of  ocular  hypertension  [18].  High  resolution  analysis  of
human eye disease has not been reported but an analysis using
in vivo NMR spectroscopy has identified lactate as a dominant
metabolite  in  human  vitreous  [19]  suggesting  that  high
resolution  metabolomic  studies  might  reveal  novel
biomarkers in human ocular disease.
In this study we have analyzed metabolite fingerprints in
vitreous  humor  from  patients  with  various  vitreoretinal
conditions,  using  high-resolution  1H-nuclear  magnetic
resonance  spectroscopy  in  conjunction  with  principal
component analysis (PCA), partial least squares discriminant
analysis  (PLS-DA),  and  multivariate  variable  selection
(MVS) for classification to determine if metabolic profiles
could define disease states.
METHODS
Patients: Patients were recruited from the tertiary referral
Vitreoretinal  Unit  of  the  Birmingham  and  Midland  Eye
Centre. A total of 42 vitreous humor samples were obtained
from patients undergoing pars plana vitrectomy for various
vitreoretinal disorders: chronic non-infectious uveitis (CU;
n=20), lens-induced uveitis LIU (n=9); proliferative diabetic
retinopathy  (PDR,  n=2),  proliferative  vitreoretinopathy
(PVR,  n=2),  rhegmatogenous  retinal  detachment  (n=7),
Candida endophthalmitis (n=1), and Varicella Zoster virus
acute retinal necrosis (ARN, n=1). The CU patients comprised
sixteen patients with panuveitis (two with sarcoidosis), two
with intermediate uveitis (pars planitis), and two with Fuchs’
heterochromic cyclitis (FHC). All of the eyes in the CU group
had chronic relapsing and remitting disease and were operated
on at a time of remission. None had ‘burnt-out disease’, The
indications for vitrectomy in the panuveitis and intermediate
uveitis patients were vitreous opacities and cystoid macular
edema  with  epiretinal  membrane  formation/vitreo-macular
traction. None of these patients had any anterior chamber
activity with the exception of FHC patients who had mild (+1)
inflammation of the AC. Of these patients, all apart from 3
were receiving systemic immunosuppression. The indication
for vitrectomy in the FHC patients was vitreous opacities, and
none  of  these  patients  were  on  any  topical  or  systemic
corticosteroid therapy. The LIU group comprised patients that
within  the  previous  14  days  had  undergone  complicated
phacoemulsification cataract surgery where the lens nucleus
had inadvertently dropped into the vitreous cavity, resulting
in an acute form of uveitis. All patients in the LIU group had
active uveitis and were receiving topical corticosteroid, and
none  were  on  systemic  anti-inflammatory  or
immunosuppressive therapy at the time of vitrectomy. Local
Research Ethics approval and patient consent was obtained in
all cases.
Metabolomic  analysis:  An  undiluted  vitreous  sample  was
taken at the beginning of surgery and was centrifuged at 300
rpm for 10 min and stored at –80 °C until analysis. After
thawing, samples (0.1 or 0.2 ml) were centrifuged at high-
speed (13,000x g), diluted 2:1 with D2O/H2O containing NaCl
(150 mM), trimethylsilyl 2,2,3,3-tetradeuteropropionic acid
(TMSP),  and  sodium  phosphate  (20  mM)  pH  7.4.  One-
dimensional  1H  spectra  were  acquired  at  298  °K  using  a
standard spin-echo pulse sequence with water suppression
using excitation sculpting on a Bruker DRX 500MHz NMR
spectrometer  equipped  with  a  cryoprobe.  Chemical  shifts
were calibrated with respect to the chemical shift position of
the TMSP resonance. Spectra were segmented into 0.005 ppm
(2.5 Hz) chemical shift ‘bins’ between 0.2 and 10.0 ppm using
ProMetab version 2 and the spectral area within each bin was
integrated [20]. Bins between 4.5 and 5.0 ppm containing
residual water were removed.
The  total  spectral  area  of  the  remaining  bins  was
normalized and the binned data describing each spectrum
were then compiled into a matrix, with each row representing
an  individual  sample.  Finally,  the  columns  were  mean-
centered before multivariate analysis.
Statistical analyses: Principal components analysis (PCA) of
the pre-processed spectra was conducted using PLS_Toolbox
(Version 4.1; Eigenvector Research, Manson, WA) within
MATLAB (version 7.5; The MathWorks, Cambridge, UK).
PCA reduces the dimensionality of data and summarizes the
similarities and differences between multiple NMR spectra
using scores plots. This requires calculation of new variables
(the PCs) that are weighted linear combinations of the original
chemical shift bins (presented as loads plots).
Partial least square discriminant analysis (PLS-DA) was
then employed using PLS_Toolbox. This validated [21,22]
supervised analysis technique was used to build a training
model to evaluate separation between groups based on known
clinical diagnosis. The PLS-DA model was cross-validated
using Venetian blinds [21,22], a method which re-assigns
randomly selected blocks of data to the PLS-DA model to
determine the accuracy of the model in correctly assigning
class membership.
Multivariate variable selection (MVS) for classification
was performed using the GALGO package [23] on the pre-
processed  spectra.  GALGO  combines  genetic  algorithm
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methods to find combinations of variables that can distinguish
between  sample  classes.  Our  analysis  identified  800
predictive gene subsets using GAs coupled to a k-nearest-
neighbor classification method. These models were pooled
and the 50 topmost frequent peaks were selected to design a
single  representative  statistical  model  using  a  forward
selection strategy. The best classification model was then
chosen.
Provisional assignment of the major peaks in the spectra
was done using Chenomx NMR Suite version 4 (Chenomx,
Edmonton,  Alberta,  Canada)  which  is  an  NMR  spectral
analysis  program  for  metabolic  profiling,  which  provides
library over 230 compounds which may be present in biofluid
samples, in conjunction with the human metabolite database
[24] and published literature [11,25]. Comparison of peak
heights of selected metabolites was made using an unpaired
Student T test.
RESULTS
NMR spectroscopy is a relatively insensitive method usually
requiring  samples  to  contain  concentrations  of  target
molecules in the high micromolar range. Our first concern was
whether useful NMR spectra could be derived from the small
vitreous humor samples available using a highly sensitive
NMR instrument equipped with a cyroprobe that is able to
minimize electronic noise in the system and thus maximize its
sensitivity to the small NMR signals from dilute samples.
Even with the small volumes available it was possible to
acquire well-resolved spectra (Figure 1A). Acquisition time
for each spectrum was relatively short, of the order of 10 min,
making it possible to process a set of samples in a reasonable
time. Although we used an NMR pulse sequence aimed at
minimizing the detrimental effects of proteins present in the
samples, which tend to produce amorphous humps within the
spectra, this seemed to be less of a problem with the vitreous
samples than with serum. The concentration of proteins in
vitreous is considerably less than that in serum and this made
a contribution to the quality of the spectra derived from these
small volumes.
The  NMR  spectra  are  data  rich  entities  but  to  make
comparison  and  analysis  possible  some  simplification  is
necessary. The first step is “binning” of the data to turn each
spectrum from a continuous analogue signal into an array of
data points. Each spectrum is segmented into approximately
2,000 regions and the area under each segment integrated.
Since  the  concentration  of  individual  samples  can  vary
considerably it is necessary to normalize the total spectral area
of each sample and the binned data describing each spectrum
were then compiled into a matrix, with each row representing
an individual sample. The spectra contained three dominant
resonances  (Figure  1A,  inset)  although  many  less-intense
peaks in the spectrum were also well resolved (Figure 1A). To
equalize the weightings of the smaller and larger peaks in the
subsequent  analysis  every  element  was  log-transformed
(Figure 1B).
Principal Components Analysis (PCA) was then applied
to the transformed datasets. With NMR data, PCA assesses
the covariance around the mean of the data in each “bin” or
region of the spectrum and assesses how these relate to each
other. The principal components (PCs) extracted from the data
describe the direction of the greatest variation in the data, and
often a relatively small number of PCs (2 or 3) are able to
describe the major covariance trends within the data. PCA
analysis of the NMR spectra from 42 samples of vitreous fluid
indicated that two principal components could account for
over 75% of the covariance and these two PCs are plotted
against  each  other  (Figure  2A).  Different  disease  groups
Figure 1. A typical 1D 1H NMR spectrum of vitreous eye fluid from
a  uveitis  patient.  A:  The  original  spectrum  labeled  to  show  the
regions in which some typical biofluid components are known to give
rise to resonances. The spectrum has been scaled to highlight the
detail; the inset is the unscaled whole spectrum. B: A data reduced
spectrum in which the region between 4.5 and 5 ppm has been deleted
so that any contribution from residual water signal is eliminated. This
spectrum has been “binned” into 0.005 Hz regions.
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Samples were distributed widely across the PC2 axis with no
particular trends apparent. There is however discrimination
based on the value of PC1, for example both PVR samples
had positive PC1 values while both PDR samples had negative
values. Similarly the patients with LIU were clustered with
samples  from  patients  with  rhegmatogenous  retinal
detachment.
This  discrimination  was  more  apparent  with  the  two
largest groups of samples, LIU and CU. When these samples
were assessed on their own, LIU samples were confined to the
left side of the PC1 plot, suggesting a negative contribution
of PC1 in these spectra while patients with CU were mainly
Figure 2. Principal components analysis of NMR spectra of vitreous
fluid from uveitis patients. The processed and binned spectra were
subjected to PCA analysis and the two major PC which accounted
for 79.9% of the variance have been plotted. A: Shows all the samples
from a broad range of uveitic conditions that were assessed: Chronic
uveitis (●), Non-inflammatory – retinal detachment (◆), PVR (▲),
PDR (□), ARN (◆), Candida (◆), ERM (■) and Lens-induced uveitis
(○).  B:  Vitreous  from  chronic  uveitis  and  lens-induced  uveitis
patients Chronic uveitis (●), Lens-induced uveitis (○). This subset of
patients was plotted since the PCA discriminated well with these
conditions.
confined to the right, suggesting a positive contribution of
PC1 (Figure 2B).
The supervised clustering analysis Partial Least Squares
Discriminant Analysis (PLS-DA) was carried out to enhance
the separation seen with the PCA. The PLS-DA model was
cross-validated  using  Venetian  blinds  [21,22],  a  method
which re-assigns randomly selected blocks of data to the PLS-
DA model to determine the accuracy of the model in correctly
assigning class membership. Using this approach an improved
separation was seen between LIU and CU in the plot of Latent
Variables (Figure 3A). PLS-DA allows a predictive model to
be generated and this was able to accurately predict which
class a sample came from (Figure 3B) with a sensitivity of
78% and specificity of 85%.
To  improve  the  classification  further,  a  Genetic
Algorithm (GA) approach was applied to remove variables
Figure 3. Partial least squares discriminant analysis (PLS-DA) of
vitreous fluid NMR spectra from lens-induced uveitis and chronic
uveitis  patients.  A  PLS-DA  model  was  constructed  to  predict
diagnostic groups. A: Latent variable plot of the PLS-DA model,
showing improved discrimination between LIU and chronic uveitis
compared with the PCA analysis (Figure 2). B: Prediction of the
group membership from the PLSDA. The model was cross validated,
and was able to predict the classes, LIU and chronic uveitis, with
sensitivity of 78% and specificity of 85%.
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models were produced and in the best of these, the number of
variables (NMR bins) was reduced to 13 that give a high
discrimination power to classify the samples from patients
with LIU and CU. The results showed that a selection of 13
bins from the spectra gave the maximum separation between
the two sets of samples (Figure 4A), and the loadings of each
bin used to define the different samples (Figure 4B). This
model was confirmed by cluster analysis and Figure 4C shows
a heat map displaying the relative contribution of each of these
regions of the spectra which shows that the discrimination was
dominated by a limited number of spectral regions, although
many other areas across the spectra contribute to the power of
the discrimination. This model was then used to classify each
sample and all LIU samples were assigned to the correct
predictive  class  (Figure  4D).  Similarly,  18/20  of  the  CU
samples  were  assigned  to  a  unique  group.  The  other  two
samples,  although  assigned  to  the  CU  group,  were  split
between class I (CU) and class II (LIU) and these were the
two samples from patients with FHC. The sensitivity and
specificity for GALGO analysis was >90% (Figure 4D).
All  three  analytical  approaches  indicated  that  the
metabolic profile were sufficiently unique in LIU and CU to
give a clear discrimination between these two groups. By
plotting the contribution of each “bin” of the spectra to the
covariance  in  the  PLS-DA  analysis  it  is  possible  to  gain
insights into categories of metabolites that may contribute to
the apparent discrimination between samples. Such loadings
for LV1 and LV2 for the data from LIU and CU in Figure 3,
can be plotted. It can be seen that the regions of the spectrum
at 5.8 ppm and from 3 to 4 ppm make a negative contribution
to LV1 as do a number of peaks between 1 and 3 ppm, while
other regions make a positive contribution. The situation is
different  with  the  LV2  plot  with  three  prominent  peaks
apparent,  but  since  LV2  does  not  segregate  the  diseases
(Figure 3) it suggests these peaks do not contribute to the
differences observed. (Figure 5A,B)
Based on these loadings plots we tentatively identified a
number  of  metabolites  represented  in  the  spectra.  Direct
comparison of the peak heights of a number of these showed
some significant differences between LIU and CU. There was
a  significant  increase  in  oxaloacetate  (p=0.0006),  glucose
(p=0.026), and urea (p=0.0003) in LIU samples compared to
CU. By comparison lactate, acetate and citrate peaks showed
no difference between the samples (Figure 5C).
DISCUSSION
This study shows for the first time that metabolomic analysis
of  vitreous  humor  samples  can  define  different  types  of
vitreoretinal disease. Specifically, two forms of uveitis, LIU
and CU, could be segregated, with samples from patients with
another  form  of  chronic  uveitis  FHC  showing  a  similar
analysis to LIU samples. Moreover the FHC samples could be
separated from LIU samples by classification analysis. In
Figure 4. Multivariate variable selection
of NMR spectra of vitreous from lens-
induced  uveitis  and  chronic  uveitis
patients. A: PCA analysis of LIU versus
chronic uveitis following GA selection
of  NMR  spectral  bins  which  best
discriminated  between  the  conditions.
833  solutions  were  found  in  2,199
search  cycles  matched  with  the
corresponding  spectra.  B:  Forward
selection procedure using the 15 most
frequent bins. The overall accuracy is
shown in the vertical axis and the ranked
bins in the horizontal axis. C: The best
model containing the 15 most frequent
bins generated by the forward selection
procedure. Bins are drawn in the vertical
axis whereas samples in the horizontal
axis.  Color  means  bin  intensity.
Hierarchical  clustering  from  bins  is
shown  for  illustrative  purposes.  D:
Prediction  of  class  (disease)
membership based on the best model.
All samples were allocatable to one of
the two classes and prediction of class
membership  could  be  made  with
sensitivity and specificity of over 90%.
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1214proliferative disease, proliferative vitreoretinopathy (PVR)
and proliferative diabetic retinopathy (PDR), samples could
be  separated,  while  non-inflammatory  retinal  detachment
samples clustered together. Finally, individual peaks could be
identified and differences in such metabolites shown to be
significantly different in the LIU and CU vitreous samples.
This data, though preliminary, shows that metabolomics could
potentially be useful in the diagnosis of, and identification of
biomarkers  in  vitreoretinal  disease.  There  are  potential
sources  of  bias  in  this  study  that  relate  to  the  patient
population.  Patients  with  CU,  with  the  exception  of
individuals with FHC were on systemic treatment for their
conditions,  while  LIU  patients  received  topical  steroids.
However, although the extent of inflammation may differ
between the groups, it only forms part of the metabolic profile
and  treatment  alone  does  not  directly  influence  the
metabolites. Secondly, it is not possible to obtain longitudinal
samples to clearly address the effect of treatment, however,
current studies on serum and urine samples will clarify this
issue.
Regardless of such caveats, the separation of LIU and
FHC from CU samples is particularly interesting. LIU could
be  termed  phacoantigenic  and  is  an  acute  granulomatous
reaction that probably represents an antigenic reaction against
proteins  released  from  the  retained  lens  fragments  after
disruption  of  the  lens  capsule  [26].  CU  samples  were
predominantly from patients with idiopathic disease with the
exception of one patient with sarcoidosis. Although there were
only two FHC samples, this condition has a distinct clinical
phenotype from other types of uveitis, and several previous
studies  have  identified  differences  between  FHC  and  CU
patients in vitreous cellular infiltrate and cytokine production,
suggesting a Th1 mediated response with CD8
+ cells  and   few
B cells as characteristic of FHC [27,28]. Recent studies have
linked  a  positive  antibody  titer  to  rubella virus to FHC,
suggesting a viral etiology supported by the cytotoxic T cell
findings  [29,30].  By  comparison,  idiopathic CU is by
definition long-standing, mediated  by  T  lymphocytes  and
inflammatory   cytokines.  How  these  different  etiologies
impact  on  themetabolome is a current area of interest.
Figure 5. Assessment of the contribution
of  regions  of  the  NMR  spectra  and
specific  metabolites  to  the
discrimination  between  lens-induced
and chronic uveitis. A: Loadings plots
from  the  PLSDA  analysis  which
indicates regions of the spectra which
provide  the  greatest  degree  of
discrimination between the two forms of
uveitis.  Positive  peaks  correspond  to
metabolites  that  are  at  higher
concentration in the chronic relative to
the LIU, and vice versa. B: Based on the
original spectra and the loadings plot,
peak heights of prominent metabolites
resonances  were  plotted  for  each
sample.  Peak  heights  were  compared
using a T test.
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reported  based  on  observations  using  in  vivo  NMR
spectroscopy with a voxel focused largely on the vitreous
region [19]. Variations in vitreous lactate levels following
induced  ocular  hypertension  in  the  rabbit  have  also  been
reported [18]. We can confirm here that lactate is present as a
major  metabolite  in  human  vitreous,  suggesting  limited
availability of oxygen within the eye. However, we saw no
significant variation in the levels between chronic and lens
induced uveitis, suggesting that the inflammatory processes
were not inducing changes in oxygen demand or delivery. The
significant differences in oxaloacetate and urea we observed
are  of  interest  in  these  inflammatory  conditions  as  both
molecules are involved in the urea cycle. In particular, urea is
produced in the metabolism of arginine to ornithine, a process
that has been described in both activated macrophages and
endothelium at the expense of nitric oxide production [31]. In
macrophages,  alternatively  activated  cells  (M2)  produce
ornithine  in  response  to  lipopolysaccharide  (LPS),  and
ornithine stimulates cell proliferation while nitric oxide is
known to inhibit such a response [32,33]. Similarly, ornithine
synthesis  has  been  described  in  human  umbilical  vein
endothelial cells (HUVEC) stimulated with cytokines and
LPS, which induce endothelial cell proliferation [34]. That
levels  of  these  molecules  were  significantly  different  in
samples from patients with LIU may be due to the nature of
the conditions, LIU presents as an acute response to lens
fragments penetrating the vitreous cavity, while CU is by
definition from patients with longstanding disease.
The cellular infiltrate present in uveitic vitreous suggests
that  leukocyte-derived  metabolites  may  contribute  to  the
profiles seen, since many of the metabolites appear to be
derived  from  intracellular  metabolic  pathways.  However,
resident  cells  might  produce  other  metabolites  so  the
discrimination  we  have  seen  may  better  reflect  the  total
cellular activity rather than metabolite production from just
infiltrating cells. While we have attempted to assign peaks to
known metabolites, the contribution of the whole spectrum of
molecules  may  be  critical  in  its  usefulness  in  disease
assessment and the MVS model we built confirms this and
shows that as few as 13 regions of the spectra can be used to
discriminate  between  samples.  The  different  processes
involved in these conditions that contribute to the metabolic
profiles are supported by analysis of factors in vitreous fluid
which showed growth factors and cytokines specific for each
disease state [35].
In conclusion, this is the first description of metabolomic
analysis  of  human  inflammatory  disease,  and  of  vitreous
samples  in  conjunction  with  appropriate  bioinformatic
analysis. The data shows a clear separation between different
disease  types  with  high  sensitivity  and  specificity.  While
prospective validation studies on both metabolic profiles and
metabolite identification are required, such global profiling is
currently being tested with regards to prognosis, diagnosis and
response  to  treatment  in  several  disease  states,  and
importantly  whether  such  discrimination  can  be  found  in
metabolic profiles from serum samples from these patients.
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